Bone Morphogenetic Protein 2-Induced Osteoblast Differentiation Requires Smad-Mediated Down-Regulation of Cdk6

REFERENCES

• Bai, S., Shi X., Yang X., and Cao X.. 2000. Smad6 as a transcriptional corepressor. J. Biol. Chem. 275:8267–8270.
   PubMedGoogle Scholar
• Chen, Q., Lin J., Jinno S., and Okayama H.. 2003. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 22:992–1001.
   PubMed Web of Science ®Google Scholar
• Deng, C., Zhang P., Harper J. W., Elledge S. J., and Leder P.. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675–684.
   PubMed Web of Science ®Google Scholar
• DiChiara, M. R., Kiely J. M., Gimbrone M. A., Jr., Lee M. E., Perrella M. A., and Topper J. N.. 2000. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J. Exp. Med. 192:695–704.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., and Weinberg R. A.. 1994. Tumor suppressor genes. Curr. Opin. Genet. Dev. 4:135–141.
   PubMed Web of Science ®Google Scholar
• Kretzschmar, M., and Massague J.. 1998. SMADs: mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 8:103–111.
   PubMed Web of Science ®Google Scholar
• Lee, K. S., Kim H. J., Li Q. L., Chi X. Z., Ueta C., Komori T., Wozney J. M., Kim E. G., Choi J. Y., Ryoo H. M., and Bae S. C.. 2000. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 20:8783–8792.
   PubMed Web of Science ®Google Scholar
• Lin, J., Jinno S., and Okayama H.. 2001. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence. Oncogene 20:2000–2009.
   PubMed Web of Science ®Google Scholar
• Lopez-Rovira, T., Chalaux E., Rosa J. L., Bartrons R., and Ventura F.. 2000. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the JunB promoter. J. Biol. Chem. 275:28937–28946.
   PubMed Web of Science ®Google Scholar
• Matushansky, I., Radparvar F., and Skoultchi A. I.. 2003. CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells. Oncogene 22:4143–4149.
   PubMed Web of Science ®Google Scholar
• Meyerson, M., Enders G. H., Wu C. L., Su L. K., Gorka C., Nelson C., Harlow E., and Tsai L. H.. 1992. A family of human cdc2-related protein kinases. EMBO J. 11:2909–2917.
   PubMed Web of Science ®Google Scholar
• Nakashima, K., Zhou X., Kunkel G., Zhang Z., Deng J. M., Behringer R. R., and de Crombrugghe B.. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17–29.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., and Loh D. Y.. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429.
   PubMed Web of Science ®Google Scholar
• Nishimori, S., Tanaka Y., Chiba T., Fujii M., Imamura T., Miyazono K., Ogasawara T., Kawaguchi H., Igarashi T., Fujita T., Tanaka K., and Toyoshima H.. 2001. Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in osteoblastic cells. J. Biol. Chem. 276:10700–10705.
   PubMed Web of Science ®Google Scholar
• Patel, M. S., and Karsenty G.. 2002. Regulation of bone formation and vision by LRP5. N. Engl. J. Med. 346:1572–1574.
   PubMedGoogle Scholar
• Reddi, A. H. 1998. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol. 16:247–252.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and Roberts J. M.. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Shi, X., Yang X., Chen D., Chang Z., and Cao X.. 1999. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J. Biol. Chem. 274:13711–13717.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Ichijo H., Fujii M., Mochida Y., Saitoh M., Nishitoh H., Sampath T. K., and Miyazono K.. 1998. Identification of a novel bone morphogenetic protein-responsive gene that may function as a noncoding RNA. J. Biol. Chem. 273:17079–17085.
   PubMedGoogle Scholar
• Tanaka, K., and Okayama H.. 2000. A Pcl-like cyclin activates the Res2p-Cdc10p cell cycle “start” transcriptional factor complex in fission yeast. Mol. Biol. Cell 11:2845–2862.
   PubMedGoogle Scholar
• Thomas, D. M., Carty S. A., Piscopo D. M., Lee J. S., Wang W. F., Forrester W. C., and Hinds P. W.. 2001. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8:303–316.
   PubMed Web of Science ®Google Scholar
• Urano, T., Yashiroda H., Muraoka M., Tanaka K., Hosoi T., Inoue S., Ouchi Y., and Toyoshima H.. 1999. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. J. Biol. Chem. 274:12197–12200.
   PubMed Web of Science ®Google Scholar
• Verschueren, K., Remacle J. E., Collart C., Kraft H., Baker B. S., Tylzanowski P., Nelles L., Wuytens G., Su M. T., Bodmer R., Smith J. C., and Huylebroeck D.. 1999. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J. Biol. Chem. 274:20489–20498.
   PubMed Web of Science ®Google Scholar
• Vidal, A., and Koff A.. 2000. Cell-cycle inhibitors: three families united by a common cause. Gene 247:1–15.
   PubMed Web of Science ®Google Scholar
• Wang, H., Goode T., Iakova P., Albrecht J. H., and Timchenko N. A.. 2002. C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest. EMBO J. 21:930–941.
   PubMedGoogle Scholar
• Yan, Y., Frisen J., Lee M. H., Massague J., and Barbacid M.. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973–983.
   PubMed Web of Science ®Google Scholar
• Yoshida, Y., Tanaka S., Umemori H., Minowa O., Usui M., Ikematsu N., Hosoda E., Imamura T., Kuno J., Yamashita T., Miyazono K., Noda M., Noda T., and Yamamoto T.. 2000. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103:1085–1097.
   PubMed Web of Science ®Google Scholar
• Zhang, P., Liegeois N. J., Wong C., Finegold M., Hou H., Thompson J. C., Silverman A., Harper J. W., DePinho R. A., and Elledge S. J.. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151–158.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. W., Yasui N., Ito K., Huang G., Fujii M., Hanai J., Nogami H., Ochi T., Miyazono K., and Ito Y.. 2000. A RUNX2/PEBP2alphaA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA 97:10549–10554.
   PubMed Web of Science ®Google Scholar
• Zhu, H., Kavsak P., Abdollah S., Wrana J. L., and Thomsen G. H.. 1999. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400:687–693.
   PubMed Web of Science ®Google Scholar
• Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–110.
   PubMed Web of Science ®Google Scholar